QualityDipStocks / Real Estate · REITs
American Healthcare REIT AHR
Outside our quality screen, so we don’t track its dips. It’s 7% below its 52-week high.
Outside our quality screen. No fair value estimate for now: there isn’t enough data.
- Fair value est.
- n/a
- Market Value
- $53.03price +1%
- Off 52-wk high
- −7%
- Risk vs market
- Lowbeta −0.05
2 bullish · 5 bearish See why
Key levels
Every level vs today’s $53.52
- 52-wk lowlowest close, 1 year$45.30−15.4%
- Market Valueavg paid since Aug 10$53.03−0.9%
- PriceFri Oct 30 close$53.52you are here
- 52-wk highhighest close, 1 year$57.72+7.8%
Fair value estimate
No estimate for AHR: Capital spending isn't tagged for the latest period in SEC XBRL data. We’d rather show nothing than a made-up number.
Risk vs market
How risk vs market is measured
One year of daily returns (Oct 30 to Oct 30, 252 sessions). Beta = how much AHR moved for each 1% move in the S&P 500 (SPY); 1.0 moves with the market. Volatility is the yearly standard deviation of daily returns. Past behavior, not a forecast.
Has moved mostly independently of the market, but its own price swings are 2.1× the S&P 500’s (it moves on its own news).
- Beta vs S&P 500
- -0.05
- Volatility
- 26% vs 13% SPY
- Correlation SPY
- −0.02
- Correlation QQQ
- −0.12
Bull vs bear
Rule-based from the data on this page, strongest first. Not advice.
Top bullish points 2 of 5
GrowthSales compounded 17% a year from FY2022 to FY2025.
GrowthSales grew 16% to $2.5B over the last 12 months vs the 12 months before (SEC filings).
Top bearish points 5 of 5
ValuationP/E of 101.6× vs a 28.7× median for the 46 Real Estate companies we cover.
Cash returnsShare count up 20.0% in a year: existing holders are being diluted.
Cash returnsPays out more in dividends than it earns: $179M paid vs $121M of net income.
ProfitabilityReturn on equity is only 4% over the last 12 months.
QualityDoesn’t pass our quality screen: no positive free cash flow; ROE under 12% and ROIC under 10%; net debt 3.2× EBITDA (limit 3×).
Who’s talking about it
Notable investors, executives, analysts and public figures on American Healthcare REIT in the last 48 hours. Headlines as published, each linked. Their words, not ours.
No notable mentions in the last 48 hours. Checked Nov 1, 9:09 PM ET.
Compare with peers
Closest in size in REITs
All fundamentals
P/E 101.6 · ROE 4% · Sales +16%
Valuation
- P/E
- 101.6×Real Estate median 28.7×
- Price / FCF
- n/anot reported in its SEC filings
- FCF yield
- n/anot reported in its SEC filings
- EV / EBITDA
- n/aD&A or debt not tagged in SEC data
- Price / sales
- 4.92×
- Price / book
- 3.33×
- Market cap
- $12.3Blisted
- Enterprise value
- n/anot reported in its SEC filings
Growth
- Revenue, 12 months
- $2.5B
- Sales growth, 12 months
- +16.4%vs the 12 months before
- Sales growth, 3 yrs
- +17.0%/yrfrom FY2022
- Diluted EPS, 12 months
- $0.68
- EPS growth, last FY
- n/afewer than two years of diluted EPS
- Net income, 12 months
- $121M
- Net income growth
- n/anot reported in its SEC filings
Profitability
- Gross margin
- 21.2%
- Operating margin
- 19.2%
- Net margin
- 4.8%
- FCF margin
- n/anot reported in its SEC filings
- Return on equity
- 4%
- Return on invested capital
- n/aoperating income, debt, equity or cash not tagged
Balance sheet
- Cash & short-term inv.
- $157M
- Total debt
- n/anot reported in its SEC filings
- Net cash
- n/acash or debt not tagged in SEC data
- Debt / equity
- n/adebt or equity not tagged in SEC data
- Interest coverage
- 6.2×operating income / interest
Cash flow & returns
- Free cash flow, 12 months
- n/anot reported in its SEC filings
- FCF growth, 12 months
- n/anot reported in its SEC filings
- Dividend yield
- 1.45%$179M paid
- Payout ratio
- 148%
- Buybacks, 12 months
- n/anot reported in its SEC filings
- Share count, 1 year
- +20.0%diluted shares vs a year ago
- Stock-based comp
- $20M
Trailing 12 months to Jun 30, 2026; balance sheet at Jun 30, 2026. From American Healthcare REIT’s SEC filings. Sparklines show up to six fiscal years. n/a means we don’t hold that number, with the reason. How each is computed.
Valuation details
MV $53.03
Setup & signals
No setup armed
No setup armed, so there’s no trigger or stop to track yet. Reversal signal rules only run on companies that pass our quality screen.
Momentum & 52-week range
RSI 55 · 5 days +0.9%
The business
Sales +25%
- Gross margin19%
- Operating margin7%
- Return on invested capital2%
- Return on equity4%
- Sales growth (latest quarter vs year-ago quarter)+25%
- Net debt / EBITDA3.1×
Next report
Nov 5
- DateThu Nov 5, after the close
- Consensus EPS$0.56
- Year-ago EPS$0.44
- QuarterSep/2026
From Nasdaq’s earnings calendar. A report resets Market Value.
Information only, not investment advice. Fair value estimates and talking points are rule-based model output from public data and can be wrong; stop levels are reference points, not orders. How every number is computed.
AHR is outside our quality screen
One text when a published rule fires on one of the 333 quality companies we track: the ticker, the price, the stop and a link to the numbers. Nothing else.